翻訳と辞書
Words near each other
・ Mallota
・ Mallota bautias
・ Mallota, Greece
・ Mallotochromene
・ Mallotojaponin
・ Mallotojaponin B
・ Mallotojaponin C
・ Mallotophenone
・ Mallotus
・ Mallotus (plant)
・ Mallotus atrovirens
・ Mallin
・ Mallinatha
・ Mallinckrodt
・ Mallinckrodt General Clinical Research Center
Mallinckrodt, Inc. v. Medipart, Inc.
・ Mallinella fulvipes
・ Malliner See
・ Malling
・ Malling Abbey
・ Malling series
・ Malling, Denmark
・ Malling, Moselle
・ Mallingbar community
・ Mallins
・ Mallinson
・ Mallinson baronets
・ Mallinson Girls School
・ Mallinson Rendel
・ Mallinātha Sūri


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

Mallinckrodt, Inc. v. Medipart, Inc. : ウィキペディア英語版
Mallinckrodt, Inc. v. Medipart, Inc.
Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700 (Fed. Cir. 1992), is a decision of the United States Court of Appeals for the Federal Circuit, in which the court appeared to overrule or drastically limit many years of U.S. Supreme Court precedent affirming the patent exhaustion doctrine, for example in Bauer & Cie. v. O'Donnell.〔Richard H. Stern, ''( The Unobserved Demise of the Exhaustion Doctrine in US Patent Law: Mallinckrodt v. Medipart )'', 15 EUR. INTELL. PROP. REV. 460 (1993).〕
==Factual background==
According to the opinions in the case, the plaintiff Mallinckrodt owned a patent on a device for dispensing a radioactive mist used in taking diagnostic lung X-rays, and for trapping the mist after use. Mallinckrodt sold the device to hospitals for about $40 or $50. Hospital personnel would load the device with a suitable radioactive fluid to perform a diagnostic procedure on a patient, use the device, and then discard it. Mallinckrodt labeled the devices it sold with the notice “Single use only.” Because the device itself cost approximately $10 to make but was sold for four or five times that, most of the purchase price that hospitals paid Mallinckrodt apparently represented the value of the patent (or the patented technology). This fact apparently led the defendant Medipart to go into the recycling business, in which Mallinckrodt itself had no direct interest (it chose to sell only new devices). For a $20 recycling fee, Medipart would clean one of the devices for a hospital, replace some parts, subject the device to gamma radiation to kill germs, and return it to the hospital for reuse. The district court and court of appeals opinions do not support the claim that a health or safety problem existed. However, Mallinckrodt asserted to the court that "potential adverse consequences, such as infectious disease transmission” provided the reason for its imposing the restriction against reuse.

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「Mallinckrodt, Inc. v. Medipart, Inc.」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.